Analysts make major calls on Tesla, Peloton, Nvidia & more amid market shifts. Discover upgrades/downgrades & insights ...

Guggenheim downgraded Snap’s stock, warning that increased AI investments could defer operating profits until 2027.

Snap Inc. shares down after Q4 report and revised price forecasts from analysts. Quarterly earnings beat estimates, but ...

A push to ban sugary drinks, candy and more from the Supplemental Nutrition Assistance Program may soon get a boost from new ...

Guggenheim analyst Michael Morris downgraded Snap (SNAP) to Neutral from Buy with a price target of $11, down from $13. Snap plans to increase ...

Snap Inc. (NYSE: SNAP) shares are moving lower Wednesday after the company reported its fourth-quarter financial results. The stock initially rose after the report but reversed course following a ...

Snapchat parent Snap Inc. wants to spend more, and that could draw out profitability even further, one Guggenheim analyst ...

Shares of CRISPR Therapeutics (NASDAQ:CRSP) were on track to snap six straight days of gains, as the stock fell more than 4% ...

A push to ban sugary drinks, candy and more from the Supplemental Nutrition Assistance Program may soon get a boost from new ...

Is now the time to buy Snap-on? Find out in our full research report. Adjusted EBITDA: $296.6 million vs analyst estimates of $361.4 million (24.7% margin, 17.9% miss) Operating Margin ...

Decoding Analyst Ratings: A Detailed Look The standing of Snap among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts ...